RVL Pharmaceuticals RVLP Stock
RVL Pharmaceuticals Price Chart
RVL Pharmaceuticals RVLP Financial and Trading Overview
| RVL Pharmaceuticals stock price | 0.03 USD |
| Previous Close | 0.82 USD |
| Open | 0.86 USD |
| Bid | 0 USD x 3000 |
| Ask | 0 USD x 900 |
| Day's Range | 0.8 - 0.86 USD |
| 52 Week Range | 0.72 - 2.99 USD |
| Volume | 66.22K USD |
| Avg. Volume | 65.7K USD |
| Market Cap | 84.45M USD |
| Beta (5Y Monthly) | 1.088701 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.17 USD |
RVLP Valuation Measures
| Enterprise Value | 106.86M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.8636365 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.2756565 |
| Price/Book (mrq) | 2.1091812 |
| Enterprise Value/Revenue | 2.879 |
| Enterprise Value/EBITDA | -2.401 |
Trading Information
RVL Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 1.088701 |
| 52-Week Change | -30.89% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.99 USD |
| 52 Week Low | 0.72 USD |
| 50-Day Moving Average | 0.91 USD |
| 200-Day Moving Average | 1.4 USD |
RVLP Share Statistics
| Avg. Volume (3 month) | 65.7K USD |
| Avg. Daily Volume (10-Days) | 52.19K USD |
| Shares Outstanding | 99.35M |
| Float | 34.08M |
| Short Ratio | 0.9 |
| % Held by Insiders | 27.03% |
| % Held by Institutions | 49.26% |
| Shares Short | 55.29K |
| Short % of Float | 0.16% |
| Short % of Shares Outstanding | 0.059% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -152.20% |
| Operating Margin (ttm) | -120.92% |
| Gross Margin | 81.64% |
| EBITDA Margin | -119.90% |
Management Effectiveness
| Return on Assets (ttm) | -21.96% |
| Return on Equity (ttm) | -103.18% |
Income Statement
| Revenue (ttm) | 37.11M USD |
| Revenue Per Share (ttm) | 0.4 USD |
| Quarterly Revenue Growth (yoy) | -58.79% |
| Gross Profit (ttm) | 43.07M USD |
| EBITDA | -44496000 USD |
| Net Income Avi to Common (ttm) | -56483000 USD |
| Diluted EPS (ttm) | -0.58 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 32.64M USD |
| Total Cash Per Share (mrq) | 0.33 USD |
| Total Debt (mrq) | 57.75M USD |
| Total Debt/Equity (mrq) | 144.38 USD |
| Current Ratio (mrq) | 2.337 |
| Book Value Per Share (mrq) | 0.403 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -30352000 USD |
| Levered Free Cash Flow (ttm) | -5449250 USD |
Profile of RVL Pharmaceuticals
| Country | United States |
| State | NJ |
| City | Bridgewater |
| Address | 400 Crossing Boulevard |
| ZIP | 08807 |
| Phone | 908 809 1300 |
| Website | https://www.rvlpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 125 |
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. It is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.
Q&A For RVL Pharmaceuticals Stock
What is a current RVLP stock price?
RVL Pharmaceuticals RVLP stock price today per share is 0.03 USD.
How to purchase RVL Pharmaceuticals stock?
You can buy RVLP shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for RVL Pharmaceuticals?
The stock symbol or ticker of RVL Pharmaceuticals is RVLP.
Which industry does the RVL Pharmaceuticals company belong to?
The RVL Pharmaceuticals industry is Biotechnology.
How many shares does RVL Pharmaceuticals have in circulation?
The max supply of RVL Pharmaceuticals shares is 111.41M.
What is RVL Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
RVL Pharmaceuticals PE Ratio is 0.00000000 now.
What was RVL Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
RVL Pharmaceuticals EPS is 0 USD over the trailing 12 months.
Which sector does the RVL Pharmaceuticals company belong to?
The RVL Pharmaceuticals sector is Healthcare.
RVL Pharmaceuticals RVLP included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}